Alumni Capital

Oncolytics Biotech Inc. is a clinical-stage biopharmaceutical company based in Calgary, Canada, focused on developing innovative therapies for cancer treatment. Its primary product, pelareorep, is an immuno-oncology agent derived from reovirus, designed to enhance the immune system's ability to target and eliminate tumors, particularly those with an activated Ras pathway. The company has established collaboration agreements with Merck KGaA and Pfizer to explore the use of pelareorep in combination with other treatments for specific types of cancer, including hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer. In addition to pelareorep, Oncolytics Biotech is advancing other projects in its pipeline aimed at various cancers, including breast and gastrointestinal cancers. Founded in 1998, Oncolytics Biotech continues to seek novel approaches to address unmet medical needs in oncology.

Safe & Green Holdings is a modular solutions company specializing in the development, design, and fabrication of innovative structures using code-engineered cargo shipping containers and wood. The company caters to the growing demand for safe and environmentally friendly solutions across various industries, including residential housing and commercial applications, such as healthcare facilities. Safe & Green operates in four main segments: construction services, medical, real estate development, and environmental. The majority of its revenue is generated from the construction segment, which includes its manufacturing unit SG ECHO and various modular projects.

V Capital Group is a team of industry experts that provides comprehensive advisory and capital-raising services across the entire capital spectrum. The firm focuses on delivering tailored solutions through its extensive experience and market knowledge, which encompasses various industries. V Capital Group's approach emphasizes a solutions-oriented methodology to corporate advisory engagements, ensuring that clients receive informed guidance and support in their financial endeavors.

V Capital Group is a team of industry experts that provides comprehensive advisory and capital-raising services across the entire capital spectrum. The firm focuses on delivering tailored solutions through its extensive experience and market knowledge, which encompasses various industries. V Capital Group's approach emphasizes a solutions-oriented methodology to corporate advisory engagements, ensuring that clients receive informed guidance and support in their financial endeavors.

Greenbrook TMS owns and operates healthcare centers providing repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases. Local electromagnetic stimulation is given during TMS therapy to certain brain areas known to be directly involved in mood regulation. Spravato is promoted to treat depressive symptoms in adults with MDD who have suicidal thoughts or behaviors as well as adults with treatment-resistant depression. In order to give patients a thorough treatment experience, Greenbrook handles insurance coverage and handles logistics while keeping the clients informed and involved in the procedure.

Azitra Inc. is a clinical-stage medical dermatology company based in Farmington, Connecticut, focused on developing microbiome-based therapeutics for skin diseases. Established in 2014, Azitra leverages its proprietary platform, which includes a microbial library of bacterial strains, to discover and create novel treatments for adverse skin conditions. The company's technology, developed in collaboration with researchers at Yale University and the Jackson Laboratory, is centered around a specific strain of the natural commensal bacteria Staphylococcus epidermidis. Additionally, Azitra employs artificial intelligence and machine learning to enhance the screening and prediction of therapeutic characteristics within its microbial library. By utilizing engineered proteins and live biotherapeutic products for topical application, Azitra aims to advance precision dermatology.

Brazil Potash aims to invest in a cleaner, sustainable future. Founded in 2009 by both Brazilian and foreign investors, the company’s foundations began with a singular goal to help achieve an independent and local output of potash in Brazil. Brazil Potash has since taken several years of exploratory drilling under proper legislation, complying with environmental studies, preparing and implementing environmental and social programs and consulting local indigenous populations to prepare for the next chapter in this company’s venture. Brazil Potash understands that potash is a key resource for farming. Potash makes soil arable, contributes to long-term farming of the same land plot, and is one of the most important exports for the agricultural sector. However, though Brazil may be one of the world’s largest and fastest-growing markets for potash, currently roughly 95% of its potash is imported from foreign countries. The company plans to begin extraction on its Autazes Potash Project, which is 120 km southeast of Manaus. Brazil Potash aims to make available up to 2,600 direct jobs during its installation phase and 1,300 during its operation phase, as well as 12 times that number in indirect positions. It also stands to connect the municipality to necessary infrastructure for quality of life, and grant the municipality increased tax revenues that can be reinvested into schools, water quality, roads and healthcare services. Brazil Potash has been recognized internationally for its plan to reduce greenhouse gas emissions caused by potash imports by upwards of 65%. Brazil Potash is led by executives who include CEO Matt Simpson, Brazil President Adriano Espeschit, Head of Finance, Davidson Aquino, geology specialists Gustavo Kiefer, Marketing Director Marcos Pedrini, Project Director Rafael Bloise and ESG Director Lúcio Rabelo. Brazil Potash’s technical headquarters is stationed in Autazes. Brazil Potash also includes a corporate office in Toronto, and its administrative branch is located in Manaus and Belo Horizonte, Brazil.